Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carol Wadham

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
British Journal of Cancer|July 21, 2020
CD30 and ALK combination therapy has high therapeutic potency in RANBP2-ALK-rearranged epithelioid inflammatory myofibroblastic sarcomaAshleigh M Fordham, Jinhan Xie, Andrew J Gifford, et al.
The Journal of Molecular Diagnostics : JMD|May 13, 2022
RNA-Based Targeted Gene Sequencing Improves the Diagnostic Yield of Mutant Detection in Chronic Myeloid LeukemiaNaranie Shanmuganathan, Carol Wadham, Daniel Thomson, et al.
Blood|September 2, 2025
Impact of ASXL1 at diagnosis in patients with CML receiving frontline potent TKIs: high risk of kinase domain mutationsNaranie Shanmuganathan, David T Yeung, Carol Wadham, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 12, 2020
Regulation of hepatic insulin signaling and glucose homeostasis by sphingosine kinase 2Gulibositan Aji, Yu Huang, Mei Li Ng, et al.
Cancer Biology & Therapy|October 10, 2018
Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancerMaria Tsoli, Carol Wadham, Mark Pinese, et al.
Haematologica|March 23, 2023
Impact of additional genetic abnormalities at diagnosis of chronic myeloid leukemia for first-line imatinib-treated patients receiving proactive treatment interventionNaranie Shanmuganathan, Carol Wadham, NurHezrin Shahrin, et al.
Blood|July 4, 2018
Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk diseaseSusan Branford, Paul Wang, David T Yeung, et al.
EMBO Molecular Medicine|December 20, 2021
In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancerLoretta M S Lau, Chelsea Mayoh, Jinhan Xie, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
British Journal of Cancer|July 21, 2020
CD30 and ALK combination therapy has high therapeutic potency in RANBP2-ALK-rearranged epithelioid inflammatory myofibroblastic sarcomaAshleigh M Fordham, Jinhan Xie, Andrew J Gifford, et al.
The Journal of Molecular Diagnostics : JMD|May 13, 2022
RNA-Based Targeted Gene Sequencing Improves the Diagnostic Yield of Mutant Detection in Chronic Myeloid LeukemiaNaranie Shanmuganathan, Carol Wadham, Daniel Thomson, et al.
Blood|September 2, 2025
Impact of ASXL1 at diagnosis in patients with CML receiving frontline potent TKIs: high risk of kinase domain mutationsNaranie Shanmuganathan, David T Yeung, Carol Wadham, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 12, 2020
Regulation of hepatic insulin signaling and glucose homeostasis by sphingosine kinase 2Gulibositan Aji, Yu Huang, Mei Li Ng, et al.
Cancer Biology & Therapy|October 10, 2018
Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancerMaria Tsoli, Carol Wadham, Mark Pinese, et al.
Haematologica|March 23, 2023
Impact of additional genetic abnormalities at diagnosis of chronic myeloid leukemia for first-line imatinib-treated patients receiving proactive treatment interventionNaranie Shanmuganathan, Carol Wadham, NurHezrin Shahrin, et al.
Blood|July 4, 2018
Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk diseaseSusan Branford, Paul Wang, David T Yeung, et al.
EMBO Molecular Medicine|December 20, 2021
In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancerLoretta M S Lau, Chelsea Mayoh, Jinhan Xie, et al.
Pageof 3